3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Squamous Cell Carcinoma of Head and Neck
4
Nasopharyngeal Carcinoma
3
Melanoma
3
Esophageal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Hepatocellular
2
Vascular Complications
1
Stomach Neoplasms
1
Spinocerebellar Degenerations
1
Solid Tumor
1
Recurrence
1
Rectal Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pathologic Complete Response
1
Oropharyngeal Neoplasms
1
Oligoprogressive
1
Neoplasms
1
Neoplasm Metastasis
1
NSCLC
1
Mouth Neoplasms
1
Meningeal Carcinomatosis
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Locally Advanced Rectal Cancer
1
Immune-Related Adverse Events
1
Glioma
1
Esophageal Squamous Cell Carcinoma
1
Diffuse Intrinsic Pontine Glioma
1
Colorectal Cancer Metastatic
1
Interventions
pembrolizumab
9
cemiplimab
7
Nivolumab
7
Ipilimumab
6
Blood Specimen Collection
4
lifileucel
2
encorafenib
2
binimetinib
2
avelumab
2
aldesleukin
2
Specimen Handling
2
Niacinamide
2
Cyclophosphamide
2
toripalimab
1
tislelizumab
1
relatlimab
1
oxycodone-acetaminophen
1
lenvatinib
1
lavender oil
1
fludarabine
1
epacadostat
1
durvalumab
1
dostarlimab
1
brodalumab
1
atezolizumab
1
Water
1
Vitamin A
1
Tissue Banks
1
Surgical Procedures, Operative
1
Sunscreening Agents
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Skin Neoplasms
×
Immune Checkpoint Inhibitors
×
90 days
×
Clear all
No trials found.